Recalls / Class II

Class IID-0939-2022

Product

NAD+ Nicotinamide Adenine Dinucleotide, Lyophilized powder for reconstitution, Multi-Dose 500 mg per vial, Rx Only, Olympia Pharmaceuticals, 6700 Conroy Rd., Ste. 155 Orlando, FL 32835. NDC 73198-0083-00.

Affected lot / code info

Lots: A2401422 BUD: 1/14/2023, K41001 BUD: 11/1/2022, K41130 BUD: 11/30/2022, L24113 BUD: 12/13/2022, L41102 BUD: 12/2/2022

Why it was recalled

Lack of assurance of sterility.

Recalling firm

Firm

Olympia Compounding Pharmacy dba Olympia Pharmacy

Notification channel

Letter

Type

Voluntary: Firm initiated

Address

6700 Conroy Rd Ste 155, Orlando, Florida 32835-3515

Distribution

Quantity

8982 vials

Distribution pattern

Distributed Nationwide in th USA, Puerto Rico and US Virgin Islands

Timeline

Recall initiated

2022-05-09

FDA classified

2022-05-25

Posted by FDA

2022-06-01

Status

Completed

Source: openFDA Drug Enforcement endpoint. Recall record D-0939-2022. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.